10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001558370-22-016295`
Period End Date	20220930
Filing Date	20221103
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	iova-20220930x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 40 Cash Flow Statement 64 Stockholders Equity 32 Comprehensive Income 12

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$118.37M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$58.59M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$78.23M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$426.18M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$241.81M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.71M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.55M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$369.88M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$507.96M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$100.75M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$100.94M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$68.98M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	157.84M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$68.27M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	157.00M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	157.84M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$91.59M	USD	Point-in-time
Long-term investments	`LongTermInvestments`	-	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	157.00M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$6.08M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$6.08M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$6.43M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$1.78M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$596.00K	USD	Point-in-time
Total Assets	`Assets`	$545.92M	USD	Point-in-time
Total Assets	`Assets`	$777.33M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$27.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$24.25M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$56.77M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$47.82M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$5.06M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$7.17M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$89.20M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$79.25M	USD	Point-in-time
Operating lease liabilities - non-current	`OperatingLeaseLiabilityNoncurrent`	$65.47M	USD	Point-in-time
Operating lease liabilities - non-current	`OperatingLeaseLiabilityNoncurrent`	$71.94M	USD	Point-in-time
Long-term note payable	`LongTermNotesPayable`	$1.00M	USD	Point-in-time
Long-term note payable	`LongTermNotesPayable`	$1.00M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$66.47M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$72.94M	USD	Point-in-time
Total Liabilities	`Liabilities`	$152.19M	USD	Point-in-time
Total Liabilities	`Liabilities`	$155.67M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 157,840,581 and 157,004,742 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 157,840,581 and 157,004,742 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-601.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.04M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.79B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.86B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.46B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.17B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$472.69M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$393.74M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$744.41M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$621.66M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$698.33M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$656.50M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$545.92M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$777.33M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$214.21M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$65.36M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$183.42M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$72.50M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$27.89M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$59.81M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$20.89M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$77.63M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$86.24M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$243.24M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$291.84M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$100.39M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-291.84M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-100.39M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-86.24M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-243.24M	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$777.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$316.00K	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$1.27M	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$120.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-242.92M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-99.62M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-290.57M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-86.12M	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-1.85	USD	3 Qtrs
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-0.63	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-1.60	USD	3 Qtrs
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-0.55	USD	1 Quarter
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-1.85	USD	3 Qtrs
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-0.63	USD	1 Quarter
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-0.55	USD	1 Quarter
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-1.60	USD	3 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	152.22M	shares	3 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	157.82M	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	155.51M	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	157.40M	shares	3 Qtrs
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	157.40M	shares	3 Qtrs
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	155.51M	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	157.82M	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	152.22M	shares	3 Qtrs

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-242.92M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-99.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-290.57M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-86.12M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$64.51M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$50.66M	USD	3 Qtrs
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$8.93M	USD	3 Qtrs
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$7.75M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.50M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.77M	USD	3 Qtrs
Accretion (amortization) of discounts and premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-5.18M	USD	3 Qtrs
Accretion (amortization) of discounts and premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.13M	USD	3 Qtrs
Loss on write-off of fixed assets	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	3 Qtrs
Loss on write-off of fixed assets	`ImpairmentOfLongLivedAssetsHeldForUse`	$314.00K	USD	3 Qtrs
Prepaid expenses, other assets and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-517.00K	USD	3 Qtrs
Prepaid expenses, other assets and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.98M	USD	3 Qtrs
Operating lease liabilities, net of tenant improvement allowance received	`IncreaseDecreaseInOperatingLeaseLiability`	$366.00K	USD	3 Qtrs
Operating lease liabilities, net of tenant improvement allowance received	`IncreaseDecreaseInOperatingLeaseLiability`	$-5.39M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-740.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.33M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-5.61M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$9.09M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-174.09M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-215.09M	USD	3 Qtrs
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$423.59M	USD	3 Qtrs
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$544.45M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$583.65M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$150.19M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$30.01M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$17.40M	USD	3 Qtrs
Net cash provided by / (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-69.21M	USD	3 Qtrs
Net cash provided by / (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$255.99M	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.65M	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	3 Qtrs
Proceeds from the issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$582.00K	USD	3 Qtrs
Proceeds from the issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$970.00K	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$29.99M	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$1.64M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$203.16M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from the issuance of debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Proceeds from the issuance of debt	`ProceedsFromIssuanceOfLongTermDebt`	$1.00M	USD	3 Qtrs
Net cash (used in) / provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$235.12M	USD	3 Qtrs
Net cash (used in) / provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-425.00K	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-8.18M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$40.48M	USD	3 Qtrs
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.85M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.31M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$124.80M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$64.67M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.85M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.31M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$124.80M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$64.67M	USD	Point-in-time
Net unrealized (loss) on investments	`UnrealizedGainLossOnInvestments`	$-24.00K	USD	3 Qtrs
Net unrealized (loss) on investments	`UnrealizedGainLossOnInvestments`	$-1.44M	USD	3 Qtrs
Acquisition of property and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$5.73M	USD	3 Qtrs
Acquisition of property and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.63M	USD	3 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	3 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$1.00K	USD	3 Qtrs
Lease liabilities arising from obtaining right-of-use asset from new leases	`Rightofuseassetobtainedinexchangeforoperatingleaseliabilityfromnewleases`	$17.27M	USD	3 Qtrs
Lease liabilities arising from obtaining right-of-use asset from new leases	`Rightofuseassetobtainedinexchangeforoperatingleaseliabilityfromnewleases`	$553.00K	USD	3 Qtrs
Lease liabilities arising from obtaining right-of-use asset from lease modifications	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromLeaseModifications`	$7.66M	USD	3 Qtrs
Lease liabilities arising from obtaining right-of-use asset from lease modifications	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromLeaseModifications`	$7.80M	USD	3 Qtrs

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$472.69M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$393.74M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$744.41M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$621.66M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$698.33M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$656.50M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.78M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.31M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$64.51M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$50.66M	USD	3 Qtrs
Common stock issued upon purchase of employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$582.00K	USD	3 Qtrs
Common stock issued upon purchase of employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$970.00K	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-2.65M	USD	3 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$225.00K	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$20.77M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.64M	USD	3 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$29.99M	USD	3 Qtrs
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$203.16M	USD	3 Qtrs
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-24.00K	USD	3 Qtrs
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.44M	USD	3 Qtrs
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$659.00K	USD	1 Quarter
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-38.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-242.92M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-99.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-290.57M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-86.12M	USD	1 Quarter
Ending Balance	`StockholdersEquity`	$472.69M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$393.74M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$744.41M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$621.66M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$698.33M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$656.50M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-242.92M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-99.62M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-290.57M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-86.12M	USD	1 Quarter
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-24.00K	USD	3 Qtrs
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.44M	USD	3 Qtrs
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$659.00K	USD	1 Quarter
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-38.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-292.01M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-242.95M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-86.16M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-98.96M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.